All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Cytochrome c oxidase (COX, complex IV) is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. Required for complex IV maintenance.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L276 | Mouse anti-dEV8 T cell receptor (2C), pCDTCR1 | 2C | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L277 | Mouse anti-dEV8 T cell receptor (q1r), pCDTCR1 | q1r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L278 | Mouse anti-dEV8 T cell receptor (q2r), pCDTCR1 | q2r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L279 | Mouse anti-dEV8 T cell receptor (q3r), pCDTCR1 | q3r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L280 | Mouse anti-dEV8 T cell receptor (q4r), pCDTCR1 | q4r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L281 | Mouse anti-dEV8 T cell receptor (q5r), pCDTCR1 | q5r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L282 | Mouse anti-dEV8 T cell receptor (q6r), pCDTCR1 | q6r | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L283 | Mouse anti-dEV8 T cell receptor (qL1), pCDTCR1 | qL1 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L284 | Mouse anti-dEV8 T cell receptor (qL2), pCDTCR1 | qL2 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L285 | Mouse anti-dEV8 T cell receptor (qL3), pCDTCR1 | qL3 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L286 | Mouse anti-dEV8 T cell receptor (qL4), pCDTCR1 | qL4 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L288 | Mouse anti-dEV8 T cell receptor (qL6), pCDTCR1 | qL6 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L289 | Mouse anti-dEV8 T cell receptor (qL7), pCDTCR1 | qL7 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L290 | Mouse anti-dEV8 T cell receptor (qL8), pCDTCR1 | qL8 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L291 | Mouse anti-dEV8 T cell receptor (qL10), pCDTCR1 | qL10 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L308 | Mouse anti-dEV8 T cell receptor (4d1), pCDTCR1 | 4d1 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L309 | Mouse anti-dEV8 T cell receptor (4d2), pCDTCR1 | 4d2 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L310 | Mouse anti-dEV8 T cell receptor (3Sd3), pCDTCR1 | 3Sd3 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L311 | Mouse anti-dEV8 T cell receptor (3dS6), pCDTCR1 | 3dS6 | Mouse | EQYKFYSV | H-2Kb | Lentiviral | ||
TCR-L312 | Mouse anti-dEV8 T cell receptor (3dS2), pCDTCR1 | 3dS2 | Mouse | EQYKFYSV | H-2Kb | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION